U.S. Biosecure Act: Will The Shift Away From Chinese Manufacturers Benefit Indian Pharma Cos?

Very positive on India CRO & CDMO space for next 4-5 years, says Sibaji Biswas, ED & CFO, Syngene International, as US considers the Biosecure Act that aims to reduce reliance on Chinese contract drug manufacturers & research organizations. Divi'sLab, Suven, Aarti Pharma & Syngene will benefit from the move, adds Vishal Manchanda, Pharma Analyst, Systematix Group.
#usbiosecureact #pharmasector #pharmacompanies #india #biotechnology #research #drugmakers #china #drugmanufacturing #cnbctv18
#businessnewstoday #businessnewsinenglish #sharemarkettoday
🔴CNBC TV18 LIVE TV: kzbin.info...
SUBSCRIBE to our Channel: bit.ly/3nvEcxf
---------------------------------------------------------------------------------------------------------------------
👑 Check Out Top CNBC TV18 Playlist Videos:
🔹Lok Sabha Elections 2024: • Playlist
🔹CNBC TV18 Digital Podcast: • I Did It My Way - CNBC...
🔹Sounding Board: • Sounding Board | CNBC ...
🔹International Videos: • World News - CNBC-TV18
🔹CNBC TV18 Market Cafe: • CNBC TV18 Market Cafe
🔹CNBC TV18 Digital: • CNBC-TV18 Digital Videos
🔹CNBC TV18 Weekend Special: • CNBC-TV18 Weekend Special
🔹CNBC TV18 Next-Gen: • CNBCTV18 Next-Gen
🔹Overdrive Show: • OVERDRIVE || CNBC TV18
🔹Young Turks: • YOUNG TURKS - The Entr...
🔹Starup Streets: • Startup Street
------------------------------------------------------------------------------------
You can also connect with CNBC-TV18 News Online
Catch the latest news: bit.ly/2YbpXBM
Follow CNBC-TV18 round the clock: www.cnbctv18.c...
Stay updated with all the market action in real time: www.cnbctv18.c...
You can also stay updated with all the latest news on-the-go with CNBC-TV18 Minis: www.cnbctv18.c...
Like us on Facebook: / cnbctv18india
Follow us on Twitter: / cnbctv18news
Follow us on Instagram: / cnbctv18india
Catch us on: Linkedin: / cnbc-tv18
n18oc_business
About CNBC-TV18: India's leading business news channel, CNBC-TV18 offers the most comprehensive coverage of businesses, the economy and the financial markets. Catch all your favourite shows, exclusive videos, big-ticket interviews and more here.

[@KrishnaSpiritual1]

Very beneficial information. I will keep an eye on these pharma companies to accumulate.

[@nistalasuresh5837]

Interesting comments 🔥

[@sagarmore7855]

MARKSANS PHARMA

[@ashishpachange317]

Call any pharma analyst,who can explain better

[@niravchudgar]

Nice piece Ekta, keep bringing differentiated analysis and discussion for the benefit of Retail investors.💊👌👏 And white looks great on you. 👌💫✨

[@thebeautifulanimal]

Stop tying. Its really annoying 😢